arrow
J

Jeffrey N. Myers

the university of texas-md anderson cancer center
H指数:86
被引数:2.7万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

BATF2 is a glutamine-responsive tumour suppressor required for type-I interferon-dependent anti-tumour immunity

BATF2是一种对谷氨酰胺敏感的肿瘤抑制因子,是I型干扰素依赖性抗肿瘤免疫所必需的。

2025-12-290
OAAI
Multimodal spatial-omics reveal co-evolution of alveolar progenitors and proinflammatory niches in progression of lung precursor lesions

多模态空间组学揭示肺前驱病变进展过程中肺泡祖细胞与促炎微环境的协同进化

2025-11-060
OAAI
Bypassing cisplatin resistance in Nrf2 hyperactivated head and neck cancer through effective PI3Kinase targeting

通过有效靶向PI3Kinase克服Nrf2高活化头颈癌的顺铂耐药性

2025-10-060
PRE
Cancer-induced nerve injury promotes resistance to anti-PD-1 therapy

癌症诱导的神经损伤促进抗PD-1疗法的耐药性

Nature
IF48.5
2025-08-200
OA
Tobacco smoke exposure is a driver of altered oxidative stress response and immunity in head and neck cancer

烟草烟雾暴露是导致头颈癌中氧化应激反应和免疫力改变的因素。

2025-04-050
OA
Clinical and prognostic differences in oropharyngeal squamous cell carcinoma in USA and Denmark, two HPV high-prevalence areas

美国和丹麦两个HPV高发地区口咽鳞状细胞癌的临床和预后差异

2024-05-012
OAAI
Mutant p53 gains oncogenic functions through a chromosomal instability-induced cytosolic DNA response

突变p53通过染色体不稳定性诱导的胞质DNA反应获得致癌功能

2024-01-0210
OAAI
Mutant p53 gains oncogenic functions through a cytosolic DNA response
2023-04-040
PRE
Evolution of cisplatin resistance through coordinated metabolic reprogramming of the cellular reductive state
2023-04-037
OA
Spatial PD-L1, immune-cell microenvironment, and genomic copy-number alteration patterns and drivers of invasive-disease transition in prospective oral precancer cohort

在前瞻性口腔癌前队列中,空间PD-L1,免疫细胞微环境和基因组拷贝数改变模式以及浸润性疾病转变的驱动因素

CANCER
IF5.1
2023-01-038
OAAI
Impact of Cancer Care Regionalization on Patient Volume
2022-12-293
PRE
Outcomes for recurrent oral cavity squamous cell carcinoma
2022-11-0117
PRE
Fusobacterium is enriched in oral cancer and promotes induction of programmed death-ligand 1 (PD-L1)
2022-09-0123
OAAI